The safety data is favorable and biomarker/clinical data of AL001 (latozinemab) is supportive of activity in this expanded group of patients. Today's data also suggests the potential for a treatment effect in other TDP pathologies (such as ALS).
ALEC has just filled its massive gap in its chart within 1 trading day. It has now nearly completely filled gap and run into support zone at the 23.5 -24 level. The gap will be completely filled at 22.5. I suspect a strong reversal from here back to the 29 level, as most gaps reverse to the next layer of resistance after they've been filled.
5 MIN OPENING RANGE BREAKOUT was good for a 7$ move.
This one is just a technical view!with mindblowing R/R!
touch the resistance and have the potential to rise.
Some things are against this trade but technicals do look great for entry . The company just happens to also be my name :). So, full disclosure, I am anchoring to that a bit ha . Here's whats against, really quick : Recent inside selling , June 3rd ( perhaps already priced in ) Short float kind of on high side slightly under 8% Here's whats for : 1.5...
NASDAQ:ALEC Hey Guys, today i´d like to showcase you a sharp ooking Long Setup for a shorter time frame. We are looking here at an uplifting and trending Bio TECH Stock that has shows previous Strenght when the market had its weakness. Alector, Inc. operates as a clinical-stage biopharmaceutical company. They are developing therapeutics for the treatment of...
Alector has completed a Wave 4 of 5 bullish move. Target is $40-45
on weekly chart, after broke out $27 it tested back and broke again. on 2 hourly chart, even though down trend is broken, rsi is still weak so worth to watch this stock for rsi break